Clarivate Plc announced on July 29, 2026, that Jonathan Collins resigned as Executive Vice President and Chief Financial Officer, effective August 7, 2026. The departure was voluntary and not due to disagreements with management or the Board. Michael Easton was appointed as his successor, effective August 8, 2026. Easton receives an initial annual base salary of $600,000, a target bonus opportunity equal to 100% of base salary, and a targeted long-term equity incentive grant valued at $2,000,000 for 2027. Additionally, he will receive a one-time promotion equity award valued at $750,000 on August 15, 2026. Clarivate Plc is a leading global provider of transformative intelligence, offering data, insights, analytics, and expert services in academia, intellectual property, and life sciences.

Clarivate Plc reported second quarter 2026 results on July 29, 2026, showing total revenues of $587.3 million and a net loss of $268.6 million, or $0.42 per diluted share. The net loss was primarily driven by a $221.7 million non-cash goodwill impairment charge associated with the divestiture of its Life Sciences & Healthcare segment. Adjusted net income was $123.1 million, or $0.19 per diluted share, and adjusted EBITDA was $247.2 million. The company reaffirmed its full-year 2026 outlook, projecting revenues between $2.30 billion and $2.42 billion and adjusted EBITDA between $980 million and $1.04 billion. Additionally, Clarivate announced the appointment of Michael Easton as Executive Vice President and Chief Financial Officer. The company operates in the intellectual property, scientific, and medical information industry.

Clarivate Plc entered into a Stock and Asset Purchase Agreement to sell its Life Sciences and Healthcare business to an affiliate of Altaris, LLC for an aggregate purchase price of $600,000,000. The consideration includes $500,000,000 in cash at closing, $25,000,000 in deferred consideration payable by January 31, 2028, and $75,000,000 in unsecured senior notes. The transaction is expected to close by the end of 2026. Clarivate provides information services and analytics for professional industries.

Clarivate Plc announced on July 6, 2026, an agreement to sell its Life Sciences and Healthcare business to an affiliate of Altaris, LLC. Clarivate operates in the information and analytics services industry, providing data and intelligence-driven solutions for professional services and professional knowledge workers.

Maroun S. Mourad, President, Intellectual Property, will depart from his position effective June 9, 2026, and will transition to an advisory role until September 30, 2026. Simon Webster will assume the role of President, Intellectual Property, effective June 10, 2026.